Please login to the form below

Not currently logged in
Email:
Password:

CicloMulsion

This page shows the latest CicloMulsion news and features for those working in and with pharma, biotech and healthcare.

Sanofi licenses cardiovascular therapy in South Korea

Sanofi licenses cardiovascular therapy in South Korea

The deal - signed by Sanofi's Asian subsidiary and covering only the South Korean market - covers a new formulation of cyclophilin inhibitor cyclosporine A - called CicloMulsion - that is in phase III ... NeuroVive's chief executive Mikael Brönnegård

Latest news

  • inVentiv extends collaboration with NeuroVive inVentiv extends collaboration with NeuroVive

    inVentiv extends collaboration with NeuroVive. Will work on commercialisation of cardiac drug CicloMulsion. ... NeuroVive and inVentiv are already discussing a broader expansion of the partnership to include future development and commercialisation

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2012 Pharma deals during November 2012

    8. Sihuan Pharmaceutical / NeuroVive Pharmaceutical. Collaboration agreement. CicloMulsion / NeuroSTAT to treat heart reperfusion / traumatic brain injuries. ... Canadian research facility. South Korea market. Pursuant to the collaboration agreement,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics